Quantitative Fluorescence Imaging of Chemophototherapy Drug Pharmacokinetics Using Laparoscopic SFDI
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125571 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Rasel Ahmmed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical, Engineering, Stony Brook University, Stony Brook, NY 11794, USA. Hauptthemen laut MEDLINE: Doxorubicin, Laparoscopy, Photochemotherapy, Optical Imaging. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health/National Cancer Institute.
Abstract (Originalsprache)
Chemophototherapy (CPT) is an emerging cancer treatment that leverages the synergistic effects of photodynamic therapy (PDT) and chemotherapy. This approach utilizes photosensitizers like Porphyrin-Phospholipid (PoP) and combined with chemotherapeutic like Doxorubicin (Dox) to enable light-triggered drug release and targeted tumor destruction. Here, we present the validation of a wide-field laparoscopic spatial frequency domain imaging (SFDI) system in an ovarian cancer model. The system allows quantitative fluorescence imaging to obtain absolute drug concentrations in vivo to obtain the absolute concentrations of PoP and Dox fluorescence by correcting for tissue absorption and scattering effects. Fluorescence imaging revealed a significant reduction (~25%, p < 0.001) in PoP concentration in tumor regions post-illumination, demonstrating PDT-mediated photobleaching. Next, the Dox release experiment showed an increase of ~13 µg/mL Dox concentration at the local site. The ability to quantify both PoP and Dox fluorescence concentrations with a laparoscopic system underscores its potential for intraoperative monitoring of CPT efficacy. These findings indicate wide-field laparoscopic SFDI as a promising tool for guiding minimally invasive PDT and targeted drug delivery in preclinical and future clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical, Engineering, Stony Brook University, Stony Brook, NY 11794, USA.
- POP Biotechnologies, Buffalo, NY 14228, USA.
- Department of Biomedical Engineering, University at Buffalo, Buffalo, NY 14260, USA.
ORCID-Profile: Elias Kluiszo, Jonathan F Lovell, Ulas Sunar
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health/National Cancer Institute
Zitieren
APA
Ahmmed, R., Kluiszo, E., Aygun-Sunar, S., Willadsen, M., Kutscher, H. L., Lovell, J. F., & Sunar, U. (2025). Quantitative Fluorescence Imaging of Chemophototherapy Drug Pharmacokinetics Using Laparoscopic SFDI. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125571
Vancouver
Ahmmed R, Kluiszo E, Aygun-Sunar S, Willadsen M, Kutscher HL, Lovell JF, et al. Quantitative Fluorescence Imaging of Chemophototherapy Drug Pharmacokinetics Using Laparoscopic SFDI. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125571
BibTeX
@article{Ahmmed2025,
author = {Ahmmed, Rasel and Kluiszo, Elias and Aygun-Sunar, Semra and Willadsen, Matthew and Kutscher, Hilliard L and Lovell, Jonathan F and Sunar, Ulas},
title = {Quantitative Fluorescence Imaging of Chemophototherapy Drug Pharmacokinetics Using Laparoscopic SFDI},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125571}
}
EUVIMED